February 17, 2012 -- Tianyin Pharma has begun construction of a new manufacturing facility in Qionglai. Phase I of Qionglai project, expected to be completed by the end of 2012, will be devoted to pre-extraction of TCM active ingredients. When Phase II is completed in 2013, Tianyin’s production capacity will be doubled. The company says its ability to supply products is constrained by the limits of its present facilities. More details....
Stock Symbol: (AMEX: TPI)
